Post by
reconsider on Sep 04, 2024 11:21am
FDA: BCG-Unresponsive. Guidance for Industry
BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drug and Biological Products for
Treatment. Guidance for Industry.
Date: August 2024.
https://www.fda.gov/media/101468/download
Sharing for whoever can understand the details in here. It's a draft guidance.